Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.5). Figures as of 19 Nov 2026, 18:05 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.2
- Combined market value
- SGD 11.55T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | SGD 5.9B | SGD 53.58 | 0.27% up | 86% up | ||
| 2 | Universal Health ServicesUHS · Health Care | 7.4 | SGD 13.1B | SGD 227.24 | 5.45% down | 17% down | ||
| 3 | Alnylam PharmaceuticalsALNY · Health Care | 7.5 | SGD 25.8B | SGD 192.84 | 0.07% down | 66% down | ||
| 4 | Tenet HealthcareTHC · Health Care | 7.7 | SGD 27.1B | SGD 340.90 | 2.74% down | 45% up | ||
| 5 | CVS HealthCVS · Health Care | 9.3 | SGD 131.7B | SGD 102.92 | 2.06% down | 7% up | ||
| 6 | Novo NordiskNVO · Health Care | 9.8 | SGD 220.4B | SGD 50.02 | 1.80% down | 17% down | ||
| 7 | Bio-Rad LaboratoriesBIO · Health Care | 9.9 | SGD 12.9B | SGD 480.53 | 0.50% up | 22% up | ||
| 8 | GrifolsGRFS · Health Care | 9.9 | SGD 7.2B | SGD 10.64 | 2.72% down | 0% up | ||
| 9 | Caris Life SciencesCAI · Health Care | 11.5 | SGD 7.1B | SGD 24.65 | 2.15% down | 19% down | ||
| 10 | Fresenius Medical CareFMS · Health Care | 11.6 | SGD 13.5B | SGD 25.93 | 4.18% down | 7% down | ||
| 11 | DaVitaDVA · Health Care | 11.7 | SGD 12.6B | SGD 199.79 | 4.40% down | 40% up | ||
| 12 | Oscar HealthOSCR · Health Care | 11.7 | SGD 10.6B | SGD 34.06 | 4.35% down | 112% up | ||
| 13 | Cigna GroupCI · Health Care | 12.0 | SGD 92.7B | SGD 351.82 | 4.56% down | 6% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | 13.0 | SGD 154.6B | SGD 75.61 | 1.72% down | 30% up | ||
| 15 | ZoetisZTS · Health Care | 14.0 | SGD 43.1B | SGD 106.15 | 3.96% down | 26% down | ||
| 16 | HCA HealthcareHCA · Health Care | 15.4 | SGD 124.9B | SGD 597.89 | 2.83% down | 0% up | ||
| 17 | Elevance HealthELV · Health Care | 16.6 | SGD 109.2B | SGD 505.45 | 2.38% down | 28% up | ||
| 18 | GSKGSK · Health Care | 16.7 | SGD 124.2B | SGD 61.95 | 1.28% down | 5% up | ||
| 19 | Ascendis PharmaASND · Health Care | 17.1 | SGD 22B | SGD 335.41 | 3.95% down | 29% up | ||
| 20 | Globus MedicalGMED · Health Care | 17.1 | SGD 11.9B | SGD 89.61 | 1.64% down | 14% down | ||
| 21 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | SGD 48B | SGD 106.18 | 1.75% down | 12% up | ||
| 22 | Boston ScientificBSX · Health Care | 18.2 | SGD 80.9B | SGD 55.84 | 0.94% down | 55% down | ||
| 23 | CencoraCOR · Health Care | 19.0 | SGD 84.1B | SGD 440.71 | 2.05% down | 4% down | ||
| 24 | UnitedHealth GroupUNH · Health Care | 19.0 | SGD 385.5B | SGD 430.19 | 4.82% down | 12% up | ||
| 25 | ExelixisEXEL · Health Care | 19.8 | SGD 20.8B | SGD 85.33 | 3.27% down | 63% up | ||
| 26 | Smith & NephewSNN · Health Care | 20.3 | SGD 16.2B | SGD 38.64 | 1.35% down | 5% down | ||
| 27 | Cooper CompaniesCOO · Health Care | 20.7 | SGD 14.8B | SGD 77.77 | 0.89% down | 15% down | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 20.7 | SGD 125.4B | SGD 1,212.33 | 0.74% down | 28% up | ||
| 29 | Encompass HealthEHC · Health Care | 21.0 | SGD 16.6B | SGD 169.63 | 2.68% down | 20% up | ||
| 30 | United TherapeuticsUTHR · Health Care | 21.3 | SGD 31B | SGD 728.87 | 2.27% down | 22% up | ||
| 31 | ResMedRMD · Health Care | 21.6 | SGD 43.1B | SGD 306.33 | 2.25% down | 1% down | ||
| 32 | CenteneCNC · Health Care | 22.3 | SGD 41.6B | SGD 83.93 | 3.67% down | 94% up | ||
| 33 | InsuletPODD · Health Care | 22.4 | SGD 12.3B | SGD 177.09 | 2.06% down | 55% down | ||
| 34 | MSA SafetyMSA · Health Care | 22.7 | SGD 8.8B | SGD 228.85 | 0.16% down | 16% up | ||
| 35 | SanofiSNY · Health Care | 22.9 | SGD 142.5B | SGD 59.36 | 2.47% down | 4% down | ||
| 36 | Option Care HealthOPCH · Health Care | 22.9 | SGD 6.1B | SGD 40.84 | 0.28% down | 12% up | ||
| 37 | Henry ScheinHSIC · Health Care | 23.1 | SGD 12B | SGD 108.92 | 1.59% down | 20% up | ||
| 38 | Halozyme TherapeuticsHALO · Health Care | 23.1 | SGD 13.6B | SGD 119.38 | 3.53% down | 39% up | ||
| 39 | Neurocrine BiosciencesNBIX · Health Care | 23.4 | SGD 20.6B | SGD 203.29 | 3.36% down | 17% up | ||
| 40 | Align TechnologyALGN · Health Care | 23.4 | SGD 14.6B | SGD 207.55 | 2.00% down | 23% up | ||
| 41 | PACS GroupPACS · Health Care | 24.0 | SGD 8.7B | SGD 54.65 | 8.63% down | 77% up | ||
| 42 | Concentra Group Holdings ParentCON · Health Care | 24.5 | SGD 6.7B | SGD 53.41 | 1.35% down | 116% up | ||
| 43 | MedtronicMDT · Health Care | 24.7 | SGD 166.4B | SGD 130.08 | 0.01% down | 1% up | ||
| 44 | AstraZenecaAZN · Health Care | 24.8 | SGD 350.6B | SGD 226.04 | 2.11% down | 1% up | ||
| 45 | Lantheus HoldingsLNTH · Health Care | 25.4 | SGD 8.6B | SGD 131.77 | 0.01% up | 90% up | ||
| 46 | AmgenAMGN · Health Care | 25.5 | SGD 307.6B | SGD 568.62 | 0.83% down | 32% up | ||
| 47 | Koninklijke PhilipsPHG · Health Care | 25.5 | SGD 37.1B | SGD 37.95 | 1.44% down | 12% up | ||
| 48 | Quest DiagnosticsDGX · Health Care | 25.8 | SGD 36.8B | SGD 334.88 | 0.17% down | 38% up | ||
| 49 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | SGD 25.1B | SGD 132.77 | 0.52% down | 16% up | ||
| 50 | ChemedCHE · Health Care | 26.3 | SGD 9.2B | SGD 708.17 | 0.28% up | 27% up | ||
| 51 | Protagonist TherapeuticsPTGX · Health Care | 26.4 | SGD 10.5B | SGD 161.03 | 1.97% down | 51% up | ||
| 52 | Ensign GroupENSG · Health Care | 26.5 | SGD 13.4B | SGD 230.33 | 2.55% down | 2% up | ||
| 53 | LivaNovaLIVN · Health Care | 26.7 | SGD 6.6B | SGD 120.14 | 1.62% down | 77% up | ||
| 54 | QiagenQGEN · Health Care | 26.8 | SGD 13.2B | SGD 63.95 | 0.11% down | 9% up | ||
| 55 | McKessonMCK · Health Care | 27.3 | SGD 157.9B | SGD 1,367.70 | 2.36% down | 28% up | ||
| 56 | NovartisNVS · Health Care | 28.9 | SGD 369.4B | SGD 195.61 | 2.44% down | 25% up | ||
| 57 | Labcorp HoldingsLH · Health Care | 30.2 | SGD 38.6B | SGD 475.52 | 0.72% down | 42% up | ||
| 58 | AvantorAVTR · Health Care | 30.2 | SGD 13.2B | SGD 19.49 | 1.82% down | 40% up | ||
| 59 | STERISSTE · Health Care | 30.3 | SGD 32B | SGD 329.45 | 1.74% down | 1% up | ||
| 60 | IQVIA HoldingsIQV · Health Care | 30.7 | SGD 53.8B | SGD 326.28 | 2.04% down | 19% up | ||
| 61 | DexComDXCM · Health Care | 31.7 | SGD 38.7B | SGD 103.86 | 2.56% down | 41% up | ||
| 62 | Merit Medical SystemsMMSI · Health Care | 31.8 | SGD 6.6B | SGD 109.52 | 1.33% down | 1% up | ||
| 63 | argenxARGX · Health Care | 32.7 | SGD 76.7B | SGD 1,219.65 | 0.31% up | 2% up | ||
| 64 | StrykerSYK · Health Care | 33.5 | SGD 154.7B | SGD 406.27 | 1.14% down | 12% down | ||
| 65 | Vertex PharmaceuticalsVRTX · Health Care | 33.8 | SGD 171.9B | SGD 678.15 | 2.14% down | 27% up | ||
| 66 | Agilent TechnologiesA · Health Care | 34.8 | SGD 64.3B | SGD 228.16 | 0.39% down | 22% up | ||
| 67 | HealthEquityHQY · Health Care | 34.8 | SGD 10.3B | SGD 124.68 | 0.81% down | 3% down | ||
| 68 | IlluminaILMN · Health Care | 35.2 | SGD 40B | SGD 264.30 | 2.57% down | 76% up | ||
| 69 | Medpace HoldingsMEDP · Health Care | 35.4 | SGD 23B | SGD 822.77 | 1.53% down | 10% up | ||
| 70 | Cardinal HealthCAH · Health Care | 35.4 | SGD 81.6B | SGD 353.14 | 1.77% down | 34% up | ||
| 71 | Thermo Fisher ScientificTMO · Health Care | 36.5 | SGD 331.6B | SGD 894.99 | 0.02% up | 21% up | ||
| 72 | Mettler-Toledo InternationalMTD · Health Care | 37.0 | SGD 43.8B | SGD 2,201.47 | 1.90% down | 24% up | ||
| 73 | HumanaHUM · Health Care | 37.1 | SGD 59B | SGD 491.12 | 1.44% down | 73% up | ||
| 74 | DanaherDHR · Health Care | 37.7 | SGD 206.8B | SGD 294.00 | 0.43% down | 3% up | ||
| 75 | Abbott LaboratoriesABT · Health Care | 38.9 | SGD 233.2B | SGD 134.65 | 0.23% down | 16% down | ||
| 76 | PfizerPFE · Health Care | 39.4 | SGD 203.3B | SGD 35.66 | 1.60% down | 15% up | ||
| 77 | Johnson & JohnsonJNJ · Health Care | 40.4 | SGD 828.2B | SGD 344.04 | 2.33% down | 34% up | ||
| 78 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.3 | SGD 16B | SGD 19.22 | 0.67% down | 8% up | ||
| 79 | Becton, DickinsonBDX · Health Care | 42.1 | SGD 74.9B | SGD 274.97 | 1.48% down | 45% up | ||
| 80 | Krystal BiotechKRYS · Health Care | 43.1 | SGD 12.1B | SGD 409.81 | 0.61% up | 54% up | ||
| 81 | Eli LillyLLY · Health Care | 43.9 | SGD 1.56T | SGD 1,747.92 | 2.14% down | 33% up | ||
| 82 | GenmabGMAB · Health Care | 44.1 | SGD 41.1B | SGD 66.59 | 1.15% up | 70% up | ||
| 83 | West Pharmaceutical ServicesWST · Health Care | 44.2 | SGD 35.4B | SGD 508.19 | 2.62% down | 57% up | ||
| 84 | Royalty PharmaRPRX · Health Care | 44.4 | SGD 50.5B | SGD 87.82 | 1.00% down | 79% up | ||
| 85 | BrightSpring Health ServicesBTSG · Health Care | 45.7 | SGD 16.6B | SGD 83.32 | 5.62% down | 109% up | ||
| 86 | IDEXX LaboratoriesIDXX · Health Care | 46.5 | SGD 70.2B | SGD 890.93 | 1.25% down | 1% up | ||
| 87 | AbbVieABBV · Health Care | 48.6 | SGD 646B | SGD 365.49 | 1.07% down | 25% up | ||
| 88 | Corcept TherapeuticsCORT · Health Care | 48.9 | SGD 9.2B | SGD 84.08 | 3.98% down | 10% down | ||
| 89 | Intuitive SurgicalISRG · Health Care | 49.8 | SGD 184.6B | SGD 532.43 | 2.08% down | 24% down | ||
| 90 | BeOne MedicinesONC · Health Care | 51.5 | SGD 59.3B | SGD 519.18 | 0.41% down | 16% up | ||
| 91 | HaemoneticsHAE · Health Care | 53.0 | SGD 7.1B | SGD 154.85 | 2.43% down | 64% up | ||
| 92 | Amneal PharmaceuticalsAMRX · Health Care | 53.4 | SGD 9.6B | SGD 27.58 | 2.42% down | 90% up | ||
| 93 | AlconALC · Health Care | 54.8 | SGD 46.6B | SGD 96.93 | 0.29% down | 0% up | ||
| 94 | IncyteINCY · Health Care | 59.2 | SGD 30.6B | SGD 149.89 | 1.49% down | 16% up | ||
| 95 | Edwards LifesciencesEW · Health Care | 60.5 | SGD 77.3B | SGD 134.43 | 1.10% down | 25% up | ||
| 96 | Bio-TechneTECH · Health Care | 66.7 | SGD 14.8B | SGD 93.92 | 0.05% down | 24% up | ||
| 97 | HeartflowHTFL · Health Care | 67.8 | SGD 5.2B | SGD 58.64 | 1.08% down | 66% up | ||
| 98 | RevvityRVTY · Health Care | 68.3 | SGD 22.2B | SGD 198.41 | 0.77% up | 62% up | ||
| 99 | Jazz PharmaceuticalsJAZZ · Health Care | 71.1 | SGD 19.9B | SGD 310.28 | 3.05% down | 41% up | ||
| 100 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.8 | SGD 9.6B | SGD 122.46 | 0.26% down | 129% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2917 SGD). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.5) have the lowest P/E ratio of the 115 health care companies ranked here as of 19 Nov 2026, 18:05 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SGD 11.55T as of 19 Nov 2026, 18:05 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.